Legal & General Group PLC Sage Therapeutics, Inc. Transaction History
Legal & General Group PLC
- $368 Billion
- Q4 2024
A detailed history of Legal & General Group PLC transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 65,924 shares of SAGE stock, worth $481,904. This represents 0.0% of its overall portfolio holdings.
Number of Shares
65,924
Previous 66,642
1.08%
Holding current value
$481,904
Previous $480,000
25.62%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding SAGE
# of Institutions
194Shares Held
45MCall Options Held
304KPut Options Held
117K-
Black Rock Inc. New York, NY5.22MShares$38.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.84MShares$35.4 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.59MShares$33.6 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V84.46MShares$32.6 Million0.48% of portfolio
-
Rtw Investments, LP New York, NY3MShares$21.9 Million0.27% of portfolio
About Sage Therapeutics, Inc.
- Ticker SAGE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,422,300
- Market Cap $434M
- Description
- Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...